1 |
Vedolizumab 300 mg |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 [1] 97 💬 |
2 |
Vedolizumab 300 mg injection [entyvio] |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [1] 96 💬 |
3 |
Vedolizumab 300 mg iv |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 [1] 97 💬 |